The US National Marrow Donor Program role in unrelated donor hematopoietic cell transplantation

Bone Marrow Transplantation
Dennis Confer, P Robinett

Abstract

The National Marrow Donor Program (NMDP) is headquartered in Minneapolis, Minnesota, USA. Established in 1986, the NMDP currently operates the world's largest registry of unrelated adult donors and umbilical cord blood (UCB) units. Since its inception, the NMDP has benefited from continuous financial support provided by the US government through a series of contracts and grant awards. This funding has supported a large network of donor centers and the recruitment of millions of potential adult hematopoietic cell (HC) donors. More recently, the federal government has also supported a national registry for UCB units and expansion of the available UCB inventories. Today, the NMDP registry lists more than 6.7 million adult donors and 68,000 UCB units. Seventy-seven percent (5.2 million) of the adult donors and virtually all of the UCB units are fully typed for HLA A, B and DR. An additional 5 million donors are available for search through international collaborations. The NMDP currently facilitates more than 3600 recipients each year totaling more than 29,000 transplants since 1987.

References

Jul 3, 2003·Bone Marrow Transplantation·G GahrtonUNKNOWN World Marrow Donor Association (WMDA)
Oct 22, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Carolyn Katovich HurleyDennis L Confer
Jul 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN Stem Cell Trialists' Collaborative Group
Jul 14, 2006·Transfusion·Jeffrey McCulloughJohn Hansen
Sep 18, 2007·Human Immunology·Martin MaiersWilliam Klitz
Nov 6, 2007·Bone Marrow Transplantation·J J van Rood, M Oudshoorn
Nov 21, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Mary EapenClaudio Anasetti

❮ Previous
Next ❯

Citations

Mar 20, 2013·Haematologica·Alois GratwohlUNKNOWN Worldwide Network of Blood and Marrow Transplantation (WBMT)
Jan 1, 2011·Revista brasileira de hematologia e hemoterapia·Fernanda de Paula EduardoLuciana Corrêa
Aug 5, 2015·Journal of Clinical Medicine·Nelli BejanyanClaudio Brunstein
Jun 15, 2013·Transfusion·Jong Hyun YoonKyou Sup Han
Aug 31, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Juliet N BarkerMarcel R M van den Brink
Feb 24, 2009·Leukemia & Lymphoma·Christopher Naugler, Robert Liwski
Jan 18, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Paul A CarpenterStella M Davies
Mar 29, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Syed O A AhmedMahmoud Aljurf
Dec 15, 2010·Blood·Juliet N BarkerAndromachi Scaradavou
Jul 4, 2012·Oncology Nursing Forum·Lisa Mische LawsonNicole Wright
Jan 31, 2018·Palliative & Supportive Care·Christina MangurianJulia Kearney
Jun 19, 2018·Disaster Medicine and Public Health Preparedness·John L HickJohn F Koerner
Oct 16, 2015·Clinical Journal of the American Society of Nephrology : CJASN·Cheryl L JacobsUNKNOWN RELIVE Study Group
Sep 29, 2011·Current Opinion in Hematology·William ArceseAlessandra Picardi
Nov 16, 2020·The International Journal of Biochemistry & Cell Biology·Alexander T Dilthey
Mar 27, 2018·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Galen E SwitzerMary Amanda Dew

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.